Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BIO Proposes Increased Imputed Base Rates for 2002 Medicare OPPS

This article was originally published in The Gray Sheet

Executive Summary

The Biotechnology Industry Organization (BIO) says it will seek a blended reimbursement rate of 80% of the average wholesale price (AWP) for drugs and biologics if the trade group is unable to delay the Centers for Medicare & Medicaid Services' 68.9% pro rata reduction in "pass-through" payments for new medical technologies

You may also be interested in...

Medicare OPPS Administrative Burden On CMS Is Of Concern To MedPAC

The Medicare Payment Advisory Commission's upcoming recommendation on the future of the hospital outpatient prospective payment system (OPPS) "pass-through" payments is likely to hinge on the panel's perception of the size of the administrative undertaking for the Center for Medicare & Medicaid Services in implementing the system

QUOTED. 6 April 2020. Bethany Hills.

Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts